awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35048950-0B577091-9287-4BBF-ACB6-863C9D23A06C
Q35048950-0B577091-9287-4BBF-ACB6-863C9D23A06C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35048950-0B577091-9287-4BBF-ACB6-863C9D23A06C
Cellular effects of everolimus and sirolimus on podocytes.
P2860
Q35048950-0B577091-9287-4BBF-ACB6-863C9D23A06C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35048950-0B577091-9287-4BBF-ACB6-863C9D23A06C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
037b609d0eeeda62b981c463813e517d1bf6eb2a
P2860
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.